Catechol-O-methyltransferase (COMT) gene variants and pain in chronic pancreatitis

Netherlands Journal of Medicine

Volumn 69, Issue 7, 2011, Pages 330-334

  van Esch, A A J ^a   de Vries, E ^a   te Morsche, R H M ^a   van Oijen, M G H ^a   Jansen, J B M J ^a   Drenth, J P H ^a  

^a RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

Chronic pancreatitis; COMT; Pain; Polymorphism

Indexed keywords

CATECHOL METHYLTRANSFERASE;

ADOLESCENT; ADULT; AGED; ARTICLE; CHRONIC PAIN; CHRONIC PANCREATITIS; CONTROLLED STUDY; DIPLOIDY; DIPLOTYPE; DISEASE SEVERITY; FEMALE; GENE FREQUENCY; GENETIC ASSOCIATION; GENETIC VARIABILITY; GENOTYPE; HUMAN; MALE; NOCICEPTION; SINGLE NUCLEOTIDE POLYMORPHISM;

ADOLESCENT; ADULT; AGED; CASE-CONTROL STUDIES; CATECHOL O-METHYLTRANSFERASE; CROSS-SECTIONAL STUDIES; FEMALE; GENETIC PREDISPOSITION TO DISEASE; HAPLOTYPES; HUMANS; LINKAGE DISEQUILIBRIUM; MALE; MIDDLE AGED; NETHERLANDS; PAIN; PANCREATITIS, CHRONIC; POLYMORPHISM, SINGLE NUCLEOTIDE;

EID: 80053918559     PISSN: 03002977     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (33)

1. Garg PK, Tandon RK. Survey on chronic pancreatitis in the Asia-Pacific region. J Gastroenterol Hepatol. 2004;19(9):998-1004.
2. Van Esch AA, Wilder-Smith OH, Jansen JB, et al. Pharmacological management of pain in chronic pancreatitis. Dig Liver Dis. 2006;38(7):518-26.
3. Mogil JS. The genetic mediation of individual differences in sensitivity to pain and its inhibition. Proc Natl Acad Sci U S A. 1999;96(14):7744-51.
4. Reimann F, Cox JJ, Belfer I, et al. Pain perception is altered by a nucleotide polymorphism in SCN9A. Proc Natl Acad Sci USA. 2010;107(11):5148-53.
5. Diatchenko L, Nackley AG, Slade GD, et al. Catechol-O-methyltransferase gene polymorphisms are associated with multiple pain-evoking stimuli. Pain. 2006;125(3):216-24.
6. Hagen K, Pettersen E, Stovner LJ, et al. The association between headache and Val158Met polymorphism in the catechol-O-methyltransferase gene. J Headache Pain. 2006;7(2):70-4.
7. Hagen K, Pettersen E, Stovner LJ, Skorpen F, Zwart JA. No association between chronic musculoskeletal complaints and Val158Met polymorphism in the Catechol-O-methyltransferase gene. The HUNT study. BMC Musculoskelet Disord. 2006;7:40.
8. Armero P, Muriel C, Santos J, et al. COMT (Val158Met) polymorphism is not associated to neuropathic pain in a Spanish population. Eur J Pain. 2005;9(3):229-32.
9. Zubieta JK, Heitzeg MM, Smith YR, et al. COMT val158met genotype affects mu-opioid neurotransmitter responses to a pain stressor. Science. 2003;299(5610):1240-3.
10. Vargas-Alarcon G, Fragoso JM, Cruz-Robles D, et al. Catechol-Omethyltransferase gene haplotypes in Mexican and Spanish patients with fibromyalgia. Arthritis Res Ther. 2007;9(5):R110.
11. Jensen KB, Lonsdorf TB, Schalling M, et al. Increased sensitivity to thermal pain following a single opiate dose is influenced by the COMT val(158)met polymorphism. PLoS One. 2009;4(6):e6016.
12. Lee PJ, Delaney P, Keogh J, et al. Catecholamine-o-methyltransferase polymorphisms are associated with postoperative pain intensity. Clin J Pain. 2011;27(2):93-101.
13. McLean SA, Diatchenko L, Lee YM, et al. Catechol O-methyltransferase haplotype predicts immediate musculoskeletal neck pain and psychological symptoms after motor vehicle collision. J Pain. 2011;12(1):101-7.
14. Reyes-Gibby CC, Shete S, Rakvag T, et al. Exploring joint effects of genes and the clinical efficacy of morphine for cancer pain. Pain. 2006;17:1-7.
15. Rakvag TT, Klepstad P, Baar C, et al. The Val158Met polymorphism of the human catechol-O-methyltransferase (COMT) gene may influence morphine requirements in cancer pain patients. Pain. 2005;116(1-2):73-8.
16. Cumming P, Brown E, Damsma G, et al. Formation and clearance of interstitial metabolites of dopamine and serotonin in the rat striatum. J Neurochem. 1992;59(5):1905-14.
17. Li PP, Warsh JJ, Godse DD. Formation and clearance of norepinephrine glycol metabolites in mouse brain. J Neurochem. 1984;43(5):1425-33.
18. Zubieta JK, Smith YR, Bueller JA, et al. Regional mu opioid receptor regulation of sensory and affective dimensions of pain. Science. 2001;293(5528):311-5.
19. Nackley AG, Tan KS, Fecho K, et al. Catechol-O-methyltransferase inhibition increases pain sensitivity through activation of both beta2-and beta3-adrenergic receptors. Pain. 2007;128(3):199-208.
20. Mannisto PT, Kaakkola S. COMT: biochemistry, molecular biology, pharmacology, and clinical efficacy of the new selective COMT inhibitors. Pharmacol Rev. 1999;51(4):593-628.
21. Lotta T, Vidgren J, Tilgmann C, et al. Kinetics of human soluble and membrane-bound catechol O-methyltransferase. Biochemistry. 1995;34(13):4202-10.
22. Nackley AG, Shabalina SA, Lambert JE, et al. Low enzymatic activity haplotypes of the human catechol-O-methyltransferase gene: enrichment for marker SNPs. PLoS One. 2009;4(4):e5237.
23. Diatchenko L, Slade GD, Nackley AG, et al. Genetic basis for individual variations in pain perception and the development of a chronic pain condition. Hum Mol Genet. 2005;14(1):135-43.
24. Howes N, Lerch MM, Greenhalf W, et al. Clinical and genetic characteristics of hereditary pancreatitis in Europe. Clin Gastroenterol Hepatol. 2004;2(3):252-61.
25. www.genetik.charite.de. Tests for Hardy-Weinberg equilibrium.
26. www.broadinstitute.org/scientific-community/science/programs/ medical-and-population-genetics/haploview/haploview.
27. Derikx MH, Drenth JP. Genetic factors in chronic pancreatitis; implications for diagnosis, management and prognosis. Best Pract Res Clin Gastroenterol. 2010;24(3):251-70.
28. Drenth JP, te Morsche R, Jansen JB. Mutations in serine protease inhibitor Kazal type 1 are strongly associated with chronic pancreatitis. Gut. 2002;50(5):687-92.
29. Witt H, Sahin-Toth M, Landt O, et al. A degradation-sensitive anionic trypsinogen (PRSS2) variant protects against chronic pancreatitis. Nat Genet. 2006;38(6):668-73.
30. Hallikainen T, Lachman H, Saito T, et al. Lack of association between the functional variant of the COMT gene and early-onset alcoholism associated with severe antisocial behavior. Am J Med Genet. 2000;96(3):348-52.
31. Tiihonen J, Hallikainen T, Lachman H, et al. Association between the functional variant of the catechol-O-methyltransferase (COMT) gene and type 1 alcoholism. Mol Psychiatry. 1999;4(3):286-9.
32. Kauhanen J, Hallikainen T, Tuomainen TP, et al. Association between the functional polymorphism of catechol-O-methyltransferase gene and alcohol consumption among social drinkers. Alcohol Clin Exp Res. 2000;24(2):135-9.
33. Foroud T, Wetherill LF, Dick DM, et al. Lack of association of alcohol dependence and habitual smoking with catechol-O-methyltransferase. Alcohol Clin Exp Res. 2007;31(11):1773-9.